Annals of Internal Medicine, tip sheet, January 21, 2003

January 20, 2003

Chemotherapy After Breast Cancer Surgery Not Used as Often as Recommended

A new study finds that many women do not receive adjuvant chemotherapy after surgery for breast cancer as recommended by National Institutes of Health (NIH) consensus conferences (Article, p. 90). Further, the older the woman, the less likely she was to receive adjuvant chemotherapy. Data from a statewide tumor registry of women diagnosed with early-stage breast cancer between 1991 and 1997 showed that, overall, 29 percent of women received chemotherapy. Analyzed by age, chemotherapy was used by 66 percent of women younger than 45, with use decreasing substantially with age. Only 18 percent of women between 60 and 64 received adjuvant chemotherapy; 12 percent of women between 65 and 69, and 3 percent of those older than 75. The NIH recommends adjuvant chemotherapy for women whose breast cancer has spread to lymph nodes and for women who have a tumor larger than 1 centimeter. Authors say that the study does not address whether the NIH recommendations are overly aggressive or whether practicing oncologists are too conservative in their use of chemotherapy.

Women with Heart Disease Are at High Risk for Heart Attacks, But Often Are Not Taking Appropriate Preventive Drugs, New Study Finds

Using data from the Heart and Estrogen/Progestin Replacement Study (HERS), researchers found that women with known heart disease were at high risk for future heart events and their risk increased up to sixfold when they had many additional risk factors (Article, p. 81). Researchers identified 11 easily assessed characteristics that predicted future heart events. They also found that although all the women had heart disease, only half or fewer were taking established drugs for secondary prevention of heart disease. In fact, women who had the greatest risk for future coronary events were the least likely to be treated with aspirin or cholesterol-lowing drugs.

Denver Health: An Integrated, Successful Urban Safety-Net System
(Medicine and Public Issues, p. 143).
-end-
Annals of Internal Medicine is published by the American College of Physicians-American Society of Internal Medicine (ACP-ASIM), an organization of more than 115,000 internal medicine physicians and medical students. The following highlights are not intended to substitute for articles as sources of information. For an embargoed fax of an article, call 1-800-523-1546, ext. 2656, or 215-351-2656.

American College of Physicians

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.